ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Arrowhead Pharmaceuticals, INC.

Official 2024 U.S. DOL Form 5500 summary for Arrowhead Pharmaceuticals, INC. (Arrowhead 401(k) Plan And Trust · EIN 46-0408024 · PN 001): $60.30M net assets, 611 active participants, and $22.20 per $10,000 (22.20 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorArrowhead Pharmaceuticals, INC.
Filing IdentifierArrowhead 401(k) Plan And Trust · EIN 46-0408024 · PN 001
Plan Category & State401(k) Defined Contribution (CA)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$60.30M
Active Participants611
Direct Admin Fee Rate$22.20 per $10,000 (22.20 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI